The Clorox Company
General ticker "CLX" information:
- Sector: Consumer Staples
- Industry: Household & Personal Products
- Capitalization: $13.8B (TTM average)
The Clorox Company does not follow the US Stock Market performance with the rate: -34.6%.
Estimated limits based on current volatility of 2.1%: low 94.67$, high 98.79$
Factors to consider:
- Earnings expected soon, date: 2026-07-30 amc
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-04-22, amount 1.24$ (Y5.15%)
- Total employees count: 7600 (-5.0%) as of 2025
- US accounted for 84.0% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Economic downturns and volatility, Market competition, Supply chain disruptions, Cybersecurity threats, Regulatory and compliance
- Current price 10.3% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [101.08$, 150.84$]
- 2026-06-30 to 2027-06-30 estimated range: [107.44$, 157.88$]
Financial Metrics affecting the CLX estimates:
- Negative: with PPE of 15.6 at the end of fiscal year the price was high
- Positive: 7.57 < Operating profit margin, % of 16.60
- Positive: -0.03 < Operating cash flow per share per price, % of 6.57
- Positive: Inventory ratio change, % of -1.38 <= -0.75
- Positive: Return on assets ratio (scaled to [-100,100]) of 12.91 > 6.02
- Positive: Industry inventory ratio change (median), % of -0.74 <= -0.15
- Negative: 0.01 < Interest expense per share per price, % of 0.59
- Negative: Shareholder equity ratio, % of 5.77 <= 19.19
Short-term CLX quotes
Relationship graph
Long-term CLX plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $7,389.00MM | $7,093.00MM | $7,104.00MM |
| Operating Expenses | $6,562.00MM | $6,177.00MM | $5,925.00MM |
| Operating Income | $827.00MM | $916.00MM | $1,179.00MM |
| Non-Operating Income | $-589.00MM | $-518.00MM | $-101.00MM |
| Interest Expense | $90.00MM | $90.00MM | $88.00MM |
| R&D Expense | $138.00MM | $126.00MM | $121.00MM |
| Income(Loss) | $238.00MM | $398.00MM | $1,078.00MM |
| Taxes | $77.00MM | $106.00MM | $254.00MM |
| Net Income(Loss)* | $149.00MM | $280.00MM | $810.00MM |
| Stockholders Equity | $220.00MM | $328.00MM | $321.00MM |
| Inventory | $696.00MM | $637.00MM | $523.00MM |
| Assets | $5,945.00MM | $5,751.00MM | $5,561.00MM |
| Operating Cash Flow | $1,158.00MM | $695.00MM | $981.00MM |
| Capital expenditure | $228.00MM | $212.00MM | $220.00MM |
| Investing Cash Flow | $-223.00MM | $-175.00MM | $-94.00MM |
| Financing Cash Flow | $-753.00MM | $-655.00MM | $-924.00MM |
| Earnings Per Share** | $1.21 | $2.25 | $6.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.